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ABSTRACT 
Objective: Objective of the study was to design, fabricate & evaluate punch die set for accurate sizing of sodium cromoglycate ocular inserts 
prepared using few polymers and to compare with physico-chemical results of manually sized inserts. 
Methods: The formulated ocular inserts were sized manually and by using punch die set. Ocular inserts sized by manual cutting & stainless steel 
316 (SS 316) punch die set was compared and evaluated for various important physico-chemical parameters.  
Results: Phenomenal differences were observed in all evaluated parameters like appearance, thickness, drug content and drug release studies. 
Ocular inserts sized using punch die set had improved appearance, uniform thickness both near the edges & in the center of insert and accurate 
drug content when compared to ocular inserts that were sized manually. Drug release studies were better for punch die sized inserts as against 
manually sized inserts. 
Conclusion: Ocular inserts sized by punch die set was superior when compared to inserts sized manually. The results for evaluated parameters like 
appearance, thickness, drug content and drug release studies were accurate, uniform and consistent. 
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INTRODUCTION 
Eye is a sensitive organ of vision and a challenging subject for topical 
administration of drugs. A major goal of pharmaco therapeutics is 
the attainment of an effective drug concentration at the intended site 
of action for a desired period of time[1]. It was decided to formulate 
and evaluate sodium cromoglycate extended release ocular inserts 
for allergic conjunctivitis. Extended release ocular inserts can 
overcome the limitations of conventional ophthalmic dosage forms 
thus improving patient compliance with increased therapeutic 
efficacy [1]. 
Chemically, sodium cromoglycate is disodium 4,4’-dioxo-5,5’-(-2-
hydroxy trimethylenedioxy) di (chromene -2-carboxylate) with a 
molecular weight of 512.3. Its molecular formula is C23H14Na2O11. 
Three polymers were used to prepare ocular films. A novel natural 
polymer Pullulan, synthetic polymer namely, Hydroxy ethyl cellulose 
(HEC) and Gelatin of natural origin were used. Pullulan is a water-
soluble neutral polysaccharide produced from starch syrup by 
fermentation. Available as a white powder, it is essentially odorless, 
flavorless, and stable [3].  
The drug is official in major pharmacopoeias like BP, USP and also in 
Indian Pharmacopoeia (IP) [2]. 
The good binding and film-forming properties of Pullulan make it a 
valuable ingredient for coating tablet. Pullulan can also be used to 
make non-animal capsules and has the same exceptional oxygen 
barrier function as the film [3]. Pullulan is listed on the USP-NF 
(United States Pharmacopoeia-National Formulary). On the other 
hand, HEC is partially substituted 2-hydroxyethyl ether of cellulose. 
It is white, odorless, tasteless, free flowing powder softens at 137°C. 
Pharmaceutically it is used as a thickener, binder, suspending agent 
in lotions and ophthalmic solutions [4]. Gelatin is vitreous, brittle 
solid and is faintly yellow in color. It has got excellent film forming 
property [4]. 
Stainless steel 316 (SS 316) was used to fabricate and develop punch 
die set for accurate sizing of oval shaped ocular inserts having 
dimension of 8 mm x 5 mm. This In House (IH) SS 316 punch die set 
was fabricated mainly to avoid variations while manual sizing of 
oval shaped ocular inserts.  
MATERIALS AND METHODS 
Materials 
(i) Drug and excipients 
Sodium cromoglycate was provided by M/s Marck biosciences Ltd, 
Ahmedabad as a gift sample, Pullulan was procured from TCI Japan, 
Hydroxyethyl cellulose was received from Color con India as a gift 
sample, Gelatin was received as a gift sample from SPI Pharma, 
Bangalore. 
(ii) Equipment  
Hot air oven (Osworld lab oven), IH fabricated glass mould, IH 
fabricated SS 316 punch die set, Shimadzu UV Visible 
spectrophotometer (UV 1601 PC), Mettler Toledo Electronic 
weighing balance, Calibrated pH meter (EUTECH pH 510), Remi 
stirrer, Stainless steel scissor and Vernier calipers (Mitutoyo, Japan). 
Methods 
Standard plot 
Sodium cromoglycate is official in Pharmacopoeia’s like IP, BP & 
USP. Indian Pharmacopoeial method was adopted and standard plot 
of Sodium cromoglycate was carried out using Phosphate buffer 
saline (PBS) of pH 7.4 [2]. 
 
 
Fig. 1: Standard plot of Sodium Cromoglycate 
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Preparation, standardization of glass mould & In-House 
fabricated SS punch die set to cut ocular inserts 
In-House fabricated mould made of virgin glass was standardized 
and used. Each mould was standardized and calculated for number 
of films that can be prepared for each batch using a particular coded 
mould. In house designed punch die set was locally fabricated that 
was made of stainless steel (Grade – SS 316) punch to size uniform 
oval shaped ocular inserts of dimension 8 mm x 5 mm. Glass mould, 
punch die set and oval ocular insert is represented below. (The oval 
shaped insert is shown in fig. 2 on the extreme right side) 
Strength per insert 
6 mg of Sodium cromoglycate was included in each extended release 
ocular insert.  
Formulation of extended release ocular inserts 
Accurately weighed amount of respective polymer was taken and 
dispersed in known quantity of water for hydration (few minutes) 
and this was stirred using remi stirrer at 2500 rpm for 25 to 30 
minutes for uniform dispersion. Accurately weighed required 
amount of drug (for each mould) was added to above viscous 
solution and stirred at 2500 rpm for about 10 minutes. PEG 400 was 
added as plasticizer and mixed well for uniformity. The resultant 
mass was poured into a glass mould with and it was dried in tray 
drier at 50° to 55° C for 4 hours. The dried film was removed 
carefully and cutting was done both manually as well by using SS 
316 punch die set. For manual sizing, punch was used, where the 
punch impression on ocular insert was used to cut inserts manually 
by using a sharp stainless steel scissor. 
  
   
Fig. 2: In-House fabricated glass mould and punch die set and a ocular film of oval shape is shown in extreme right side. 
 
Table 1: Composition of polymers and plasticizers in formulations 
Formulation code Polymer & concentration Plasticizer* Drug content in each insert 
FC 1 Pullulan 10% w/v PEG 400 6 mg 
FC 2 HEC 10% w/v PEG 400 6 mg 
FC 3 Gelatin 10% w/v PEG 400 6 mg 
*Based on polymer weight 
 
Evaluation of ocular inserts 
Ocular inserts sized manually and using SS 316 punch die set was 
evaluated for various physico-chemical tests like Appearance or 
description, thickness, drug content and in vitro drug release studies 
by In-House (IH) vial method [5-7]. In-House vial method was used 
to determine the rate of drug dissolution from the inserts. The 
dissolution medium used was Phosphate buffer saline (PBS) of pH 
7.4. The ocular insert was kept in vial containing 5 mL of PBS of pH 
7.4 and samples were withdrawn at different time points.  
It was then assayed spectrophotometrically at 327 nm after required 
dilution with release media. All of the withdrawn samples were 
replenished with equal volumes of same release medium to keep the 
release volume constant throughout the experiment. 
RESULTS AND DISCUSSIONS 
The ocular inserts prepared using three different polymers, Pullulan 
10%, HEC 10% and Gelatin 10% were biodegradable in nature. 
Ocular inserts of both the polymers showed differences with respect 
to physico-chemical properties such as appearance, thickness, drug 
content and in vitro release studies.  The results for ocular inserts 
sized manually and sized by using punch die set are shown in table 2 
and 3 respectively. The in vitro release studies are shown in fig. 3 to 
8 respectively. 
 
Table 2: Results for ocular inserts sized manually. 
Parameter 10% Pullulan inserts 10% HEC inserts 10% Gelatin inserts 
Appearance Clear to slightly opaque inserts with 
Slight uneven edges. 
Clear to slightly off white 
in color with uneven edges 
Off white to slightly 
yellow colored films 
with uneven edges 
Thickness# 
(NMT 0.40 mm) 
0.23 
Thickness near the edges was 
more when compared to center of 
inserts. 
0.19 
Thickness near the edges was 
more when compared to center of inserts. 
0.30 
Thickness near the edges 
was more when compared 
to center of inserts. 
Drug content@ 








Drug release studies 
(IH vial method) 
98.5% @ 3 hours 99.1% @ 5 hours 99.6% @ 5 hours 
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Table 3: Results for ocular inserts sized using SS 316 punch die set 
Parameter 10% Pullulan inserts 10% HEC inserts 10% Gelatin inserts 
Appearance Clear to slightly opaque inserts  
Witheven edges and smooth  
Finish 
Clear to slightly off white in color with even edges 
and smooth finish 
Off white to slightly  
yellow colored filmswith  
even edges and smooth  
finish 
Thickness# 
(NMT 0.40 mm) 
0.22 
Thickness was uniform near  
the edges and center of  
inserts. 
0.20 
Thickness was uniform near  
the edges and center of  
inserts. 
0.28 
Thickness was uniform near  
the edges and center of 
inserts. 
Drug content@ 
5.7 to 6.3 mg 
[Claim- 6mg/insert] 
6.10 6.0 6.0 
Drug release studies 
(IH vial method) 
99.4% @ 3 hours 98.3% @ 6 hours 98.8% @ 5.5 hours 
The results for appearance, thickness and drug content of table 2 and table 3 are discussed below in detail. 
 
The Appearance or Description of ocular insert sized manually was 
not of acceptable quality because of rough and uneven edges, 
whereas inserts sized by using punch die set was very good in 
appearance with even edges and fine finish. 
One of the important objectives was to maintain Thickness at not 
more than 0.40 mm. This was complying for inserts that were sized 
manually as well by using punch die set. However, it was observed 
that thickness near the edges was more when compared to thickness 
at center for the inserts that were sized manually. This was not the 
case with inserts that were sized using punch die set as the inserts 
were observed to have even thickness across inserts with even & 
accurate edges and film appearance was at its best. 
 
 
Fig. 3: In vitro release studies of sodium cromoglycate from10% 
Pullulan films (Manually sized) 
 
 
Fig. 4: In vitro release studies of sodium cromoglycate from 
10% HEC films (Manually sized) 
 
Drug content results were interesting. The input or the label claim 
for each insert was 6 mg (5.7 to 6.3 mg) i. e, 95% to 105% as per In 
House specification limit. Drug content of inserts sized by both 
manual and punch die cutting was passing. But it was noticed that 
drug content of inserts that were sized manually showed extreme 
drug content results. For 10% Pullulan inserts and 10% HEC inserts, 
the drug content was at the lower specification limits at 5.80 mg & 
5.73 mg respectively and drug content of 10% gelatin inserts was 
found to be at higher specification limit at 6.23 mg. But the drug 
content results were more precise and accurate for the inserts that 
were sized using SS 316 punch die set. The observed results were 
6.10 mg, 6.0 mg and 6.0 mg for 10% Pullulan, 10% HEC and 10% 
Gelatin inserts respectively. 
The following fig. (fig. 3 to 8) depict the in vitro drug release profiles 
of ocular inserts/films sized manually and as well by using punch die 
set. The plot shows cumulative percent drug release (CPDR) versus 
time in minutes. 
 
 
Fig. 5: In vitro release studies of sodium cromoglycate from10% 
Gelatin films (Manually sized) 
 
 
Fig. 6: In vitro release studies of sodiumcromoglycate 
from10%Pullulan films (Punch die cut films) 
 
 
Fig. 7: In vitro release studies of sodium cromoglycate from10% 
HEC films (Punch die cut films) 
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Fig. 8: In vitro release studies of sodium cromoglycate from10% 
Gelatin films (Punch die cut films) 
 
To sum up release studies, the in vitro drug release studies for punch 
die cut inserts/films were much better when compared to inserts 
that were sized manually. The drug release time was slightly delayed 
for inserts that were sized by using punch die set as compared to 
inserts sized manually. This may be due to the fact that, rough 
uneven edges of manually sized inserts ruptured faster in the 
dissolution medium.  
However there was no differences observed for 10% Pullulan 
inserts and the drug release lasted approximately for about 3 hours 
both for manually sized and punch die sized inserts. This may be due 
to property of Pullulan polymer which resulted in thin soft pliable 
films / inserts that aided in manual cutting without much difficulty 
and less damage to edges. 
CONCLUSION 
From the results, it is very much evident that phenomenal 
differences are observed with respect to physico-chemical results of 
ocular inserts that were sized manually as well by using SS 316 
punch die set. Appearance and thickness was it at best for inserts 
that were sized by using SS 316 punch die set. Drug content results 
were major concern for inserts that were sized manually, as the 
results were either at lower or upper limits with respect to 
specification.  
Drug release was delayed for inserts sized by punch die set when 
compared to manually sized inserts. Finally, it is concluded that SS 
316 punch die set shall result in an ocular insert that will comply all 
the physico-chemical parameters as per specification limits and also 
result in batch to batch consistency and reproducibility. 
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